Implantica AG
Aeulestrasse 45
Vaduz 9490
Liechtenstein
https://www.implantica.com
版塊: Healthcare
行業: Medical Devices
全職員工:
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Dr. Peter Forsell | Founder & CEO | 203.16k | 無 | 1954 |
| Mr. Andreas Öhrnberg | Chief Financial Officer | 無 | 無 | 1978 |
| Mr. Stephan Siegenthaler | Chief Strategy Officer & Board Member | 無 | 無 | 1957 |
| Ms. Nicole Pehrsson | Chief Corporate Affairs Officer | 無 | 無 | 1966 |
| Mr. Stefan Vogt | Chief Commercial Officer | 無 | 無 | 1965 |
| Mr. Amit Kukreja | Chief Market Access & Strategy Officer | 無 | 無 | 1983 |
| Mr. Jörg von Manger-Koenig | Company Secretary & Member of Advisory Board | 無 | 無 | 1960 |
描述
Implantica AG researches, develops, commercializes, and sells medical implants in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, it develops UriControl, a remote controlled artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for the treatment of aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.
公司管治
截至 無 止，Implantica AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
